腫瘍分子診断の世界市場の分析 (2020年～2030年)：新型コロナウイルス感染症 (COVID-19) による成長と変化

当レポートでは、世界の腫瘍向け分子診断の市場構造・動向について分析し、市場の主な特徴・構造や、全体的な市場規模・成長率の動向見通し (2015～2019年、2023年、2025年、2030年)、セグメント別 (製品別・技術別・エンドユーザー別) および地域別・主要国の詳細動向、主要企業のプロファイル、近年の主な傾向、今後の市場機会などを調査しております。

目次

第1章 エグゼクティブサマリー

第2章 腫瘍分子診断市場の特徴

第3章 腫瘍分子診断市場：市場規模・成長率

• 市場規模 (金額ベース、2015年～2019年)
• 市場規模 (金額ベース、2019年～2023年、2025年、2030年)
  • 市場促進要因
  • 市場抑制要因

第4章 腫瘍分子診断市場：分野別の分析

• 製品別の市場規模 (金額ベース、実績値・予測値)
  • 診断装置
  • 試薬
  • その他
• 技術別の市場規模 (金額ベース、実績値・予測値)
  • ポリメラーゼ連鎖反応（PCR）
  • In situ ハイブリダイゼーション（ISH）
  • 等温核酸増幅技術（INNAT）
  • チップ・マイクロアレイ
  • シーケンス
  • 質量分析
  • 転写媒介増幅（TMA）
  • その他
• エンドユーザー別の市場規模 (金額ベース、実績値・予測値)
  • 病院
  • 診断センター
  • 教育・研究機関
  • その他

第5章 腫瘍分子診断市場：地域別・国別分析

• 地域別の市場規模 (金額ベース、実績値・予測値)
• 国別の市場規模 (金額ベース、実績値・予測値)

第6章 アジア太平洋の腫瘍分子診断市場

• 市場概要
• 製品別の市場規模 (金額ベース、実績値・予測値)
• 技術別の市場規模 (金額ベース、実績値・予測値)

第7章 中国市場

第8章 インド市場

第9章 日本市場

第10章 オーストラリア市場

第11章 インドネシア市場

第12章 韓国市場

第13章 西欧の腫瘍分子診断市場

第14章 英国市場

第15章 ドイツ市場

第16章 フランス市場

第17章 東欧の腫瘍分子診断市場

第18章 ロシア市場

第19章 北米の腫瘍分子診断市場

第20章 米国市場

第21章 南米の腫瘍分子診断市場

第22章 ブラジル市場

第23章 中東の腫瘍分子診断市場

第24章 アフリカの腫瘍分子診断市場

第25章 腫瘍分子診断市場：競争環境と企業プロファイル

• 競争環境
• 企業プロファイル
  • Abbott Diagnostics
  • Becton Dickinson
  • Cepheid
  • Danaher Corporation
  • Beckman Coulter

第26章 腫瘍分子診断市場における主要な企業合併・買収 (M&A)

第27章 腫瘍分子診断市場の動向と戦略

第28章 腫瘍分子診断市場：将来展望と潜在力の分析

第29章 付録

“Oncology Molecular Diagnostics Global Market Report 2020-30: COVID-19 Growth And Change” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oncology molecular diagnostics market.

This report focuses on oncology molecular diagnostics market which is experiencing strong growth. The report gives a guide to the oncology molecular diagnostics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.

• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.

• Create regional and country strategies on the basis of local data and analysis.

• Identify growth segments for investment.

• Outperform competitors using forecast data and the drivers and trends shaping the market.

• Understand customers based on the latest market research findings.

• Benchmark performance against key competitors.

• Utilize the relationships between key data sets for superior strategizing.

• Suitable for supporting your internal and external presentations with reliable high quality data and analysis

• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the oncology molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Oncology Molecular Diagnostics market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider oncology molecular diagnostics market, and compares it with other markets.

• The market characteristics section of the report defines and explains the market.

• The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.

• Market segmentations break down market into sub markets.

• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.

• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

• The oncology molecular diagnostics market section of the report gives context. It compares the oncology molecular diagnostics market with other segments of the oncology molecular diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oncology molecular diagnostics indicators comparison.

Scope

Markets Covered:

• 1) By Product: Instruments; Reagents; Others

• 2) By Technology: Polymerase Chain Reaction (PCR); In-situ Hybridization (ISH); Isothermic Nucleic Acid Amplification Technology (INNAT); Chips & Microarrays; Sequencing; Mass Spectroscopy; Transcription Mediated Amplification (TMA); Others

• 3) By End User: Hospitals; Diagnostic Centers; Academic & Research Institutes; Others

• Companies Mentioned: Abbott Diagnostics; Becton Dickinson; Cepheid; Danaher Corporation; Beckman Coulter

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time Series:: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Oncology Molecular Diagnostics Market Characteristics

3. Oncology Molecular Diagnostics Market Size And Growth

• 3.1. Global Oncology Molecular Diagnostics Historic Market, 2015 - 2019, $ Billion
  • 3.1.1. Drivers Of The Market
  • 3.1.2. Restraints On The Market
• 3.2. Global Oncology Molecular Diagnostics Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
  • 3.2.1. Drivers Of The Market
  • 3.2.2. Restraints On the Market

4. Oncology Molecular Diagnostics Market Segmentation

• 4.1. Global Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• Instruments
• Reagents
• Others
• 4.2. Global Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• Polymerase Chain Reaction (PCR)
• In-situ Hybridization (ISH)
• Isothermic Nucleic Acid Amplification Technology (INNAT)
• Chips & Microarrays
• Sequencing
• Mass Spectroscopy
• Transcription Mediated Amplification (TMA)
• Others
• 4.3. Global Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• Hospitals
• Diagnostic Centers
• Academic & Research Institutes
• Others

5. Oncology Molecular Diagnostics Market Regional And Country Analysis

• 5.1. Global Oncology Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 5.2. Global Oncology Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Oncology Molecular Diagnostics Market

• 6.1. Asia-Pacific Oncology Molecular Diagnostics Market Overview
• 6.2. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 6.3. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Oncology Molecular Diagnostics Market

• 7.1. China Oncology Molecular Diagnostics Market Overview
• 7.2. China Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
• 7.3. China Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Oncology Molecular Diagnostics Market

• 8.1. India Oncology Molecular Diagnostics Market Overview
• 8.2. India Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 8.3. India Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Oncology Molecular Diagnostics Market

• 9.1. Japan Oncology Molecular Diagnostics Market Overview
• 9.2. Japan Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 9.3. Japan Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Oncology Molecular Diagnostics Market

• 10.1. Australia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 10.2. Australia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Oncology Molecular Diagnostics Market

• 11.1. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 11.2. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Oncology Molecular Diagnostics Market

• 12.1. South Korea Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 12.2. South Korea Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Oncology Molecular Diagnostics Market

• 13.1. Western Europe Oncology Molecular Diagnostics Market Overview
• 13.2. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 13.3. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Oncology Molecular Diagnostics Market

• 14.1. UK Oncology Molecular Diagnostics Market Overview
• 14.2. UK Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 14.3. UK Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Oncology Molecular Diagnostics Market

• 15.1. Germany Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 15.2. Germany Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Oncology Molecular Diagnostics Market

• 16.4. France Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 16.5. France Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Oncology Molecular Diagnostics Market

• 17.1. Eastern Europe Oncology Molecular Diagnostics Market Overview
• 17.2. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 17.3. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Oncology Molecular Diagnostics Market

• 18.1. Russia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 18.2. Russia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Oncology Molecular Diagnostics Market

• 19.1. North America Oncology Molecular Diagnostics Market Overview
• 19.2. North America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 19.3. North America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Oncology Molecular Diagnostics Market

• 20.1. USA Oncology Molecular Diagnostics Market Overview
• 20.2. USA Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 20.3. USA Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Oncology Molecular Diagnostics Market

• 21.1. South America Oncology Molecular Diagnostics Market Overview
• 21.2. South America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 21.3. South America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Oncology Molecular Diagnostics Market

• 22.1. Brazil Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 22.2. Brazil Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Oncology Molecular Diagnostics Market

• 23.1. Middle East Oncology Molecular Diagnostics Market Overview
• 23.2. Middle East Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 23.3. Middle East Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Oncology Molecular Diagnostics Market

• 24.1. Africa Oncology Molecular Diagnostics Market Overview
• 24.2. Africa Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
• 24.3. Africa Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Oncology Molecular Diagnostics Market Competitive Landscape And Company Profiles

• 25.1. Oncology Molecular Diagnostics Market Competitive Landscape
• 25.2. Oncology Molecular Diagnostics Market Company Profiles
  • 25.2.1. Abbott Diagnostics
    • 25.2.1.1. Overview
    • 25.2.1.2. Products and Services
    • 25.2.1.3. Strategy
    • 25.2.1.4. Financial Performance
  • 25.2.2. Becton Dickinson
    • 25.2.2.1. Overview
    • 25.2.2.2. Products and Services
    • 25.2.2.3. Strategy
    • 25.2.2.4. Financial Performance
  • 25.2.3. Cepheid
    • 25.2.3.1. Overview
    • 25.2.3.2. Products and Services
    • 25.2.3.3. Strategy
    • 25.2.3.4. Financial Performance
  • 25.2.4. Danaher Corporation
    • 25.2.4.1. Overview
    • 25.2.4.2. Products and Services
    • 25.2.4.3. Strategy
    • 25.2.4.4. Financial Performance
  • 25.2.5. Beckman Coulter
    • 25.2.5.1. Overview
    • 25.2.5.2. Products and Services
    • 25.2.5.3. Strategy
    • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Oncology Molecular Diagnostics Market

27. Oncology Molecular Diagnostics Market Trends And Strategies

28. Oncology Molecular Diagnostics Market Future Outlook and Potential Analysis

29. Appendix

• 29.1. Abbreviations
• 29.2. Currencies
• 29.3. Research Inquiries
• 29.4. The Business Research Company
• 29.5. Copyright And Disclaimer